Publication
This research looked at giving chemotherapy from two directions at once in advanced ovarian cancer (andashay ka cancer, अंडाशय का कैंसर) — through a vein as usual, and also as a fine spray inside the tummy during a keyhole procedure called PIPAC (pressurised intraperitoneal aerosol chemotherapy). The aim was to shrink cancer that could not be removed at first, so that full surgery might become possible.This academic work explores a bi-directional chemotherapy approach using PIPAC together with intravenous chemotherapy in advanced primary epithelial ovarian cancer. It focuses on combining intraperitoneal and systemic treatment delivery in advanced disease.
Publication
During cancer surgery with HIPEC (garam chemo, heated chemotherapy washed through the tummy), surgeons sometimes need to remove part of the bowel and join the two ends again — this join is called an anastomosis (aant jodna, आंत जोड़ना). This research asked whether it is safer to make the join before or after the heated chemotherapy. In this study the timing made no real difference to the risk of the join leaking.This academic work compares the timing of bowel anastomosis in cytoreductive surgery with HIPEC, specifically whether it is performed before or after HIPEC. It focuses on surgical sequencing within combined cytoreductive and intraperitoneal chemotherapy procedures.
Conference Presentation
Enhanced recovery after surgery (ERAS) is a set of simple, planned steps before, during and after an operation — such as preparing nutrition and fitness beforehand, shorter fasting, good pain control, and eating and walking again early — to help people recover faster and more safely. This talk discussed using ERAS for cytoreductive surgery with HIPEC (garam chemo), one of the biggest operations in cancer care.This academic work discusses enhanced recovery after surgery in the setting of cytoreductive surgery and HIPEC. It focuses on perioperative recovery pathways and care optimization around major oncologic surgery.
Academic Work
For most early womb cancer (endometrial cancer, bachedani ka cancer, बच्चेदानी का कैंसर), the main treatment is removing the womb, cervix, tubes and ovaries. Often this can be done with robotic (keyhole) surgery. This work describes a step-by-step surgical protocol the team used for robotic “type 1” hysterectomy — a standard (not radical) removal of the womb and cervix — in women with womb cancer.This academic work outlines an enhanced surgical protocol for robotic type 1 modified hysterectomy in endometrial carcinoma cases. It focuses on operative planning and technique refinement in robotic surgery for endometrial cancer.
Publication
When cancer spreads as small deposits over the thin lining inside the tummy wall (the parietal peritoneum), surgeons may strip away that lining — a peritonectomy — and then wash the tummy with heated chemotherapy (HIPEC, garam chemo). This work shows the operation done with a surgical robot, with a dye that glows under a special camera light (fluorescence) to help the surgeon see, and with “closed” HIPEC, where the tummy is closed while the heated chemotherapy circulates.This academic work describes a fluorescence-guided robotic approach to total parietal peritonectomy combined with cytoreductive surgery and closed HIPEC. It focuses on integrating robotic technique and fluorescence guidance within advanced peritoneal surface malignancy surgery.
Publication
This study, from the surgical team Dr. Nishtha Tripathi Patel was part of, looked at whether checking the blood supply of the bowel with a glowing green dye (indocyanine green, ICG) during cytoreductive surgery with HIPEC (garam chemo) helps the joined ends of the bowel heal without leaking. Its full citation and results are still being confirmed.This academic work examines the use of real-time bowel perfusion visualization with indocyanine green to assess anastomotic integrity in CRS and HIPEC cases. It focuses on intraoperative perfusion assessment during combined cytoreductive and HIPEC procedures.
Publication
This study, from the surgical team Dr. Nishtha Tripathi Patel was part of, looked at whether more complex second operations for ovarian cancer that has come back are linked with different results for patients. Its full citation and results are still being confirmed.This academic work examines how surgical complexity may influence clinical outcomes in secondary cytoreductive surgery for recurrent ovarian cancer. It focuses on the relationship between operative complexity and patient outcomes in this treatment setting.
Publication
This study, from the surgical team Dr. Nishtha Tripathi Patel was part of, looked at whether a dye called indocyanine green (ICG) can find the sentinel lymph nodes (the first glands a cancer may spread to) after chemotherapy given before surgery, in patients whose glands showed no sign of cancer at the start. Its full citation and results are still being confirmed.This academic work examines the use of indocyanine green for sentinel lymph node biopsy after neoadjuvant chemotherapy in node negative patients. It focuses on lymph node mapping after systemic treatment in a selected surgical setting.
Academic Work
This study, from the surgical team Dr. Nishtha Tripathi Patel was part of, looked at how a dye called indocyanine green (ICG), seen under a special camera, can show the surgeon how well blood reaches the bowel during cytoreductive surgery with HIPEC (garam chemo). Its full citation and results are still being confirmed.This academic work examines the use of indocyanine green to assess bowel perfusion during cytoreductive surgery with HIPEC. It focuses on intraoperative evaluation of bowel blood supply within combined surgical and HIPEC procedures.
Publication
This study, from the surgical team Dr. Nishtha Tripathi Patel was part of, compared two ways of removing the lining of the abdominal wall during cytoreductive surgery with HIPEC (garam chemo) for advanced ovarian cancer: removing the whole lining, or only the parts that look involved by cancer. Its full citation and results are still being confirmed.This academic work compares complete total parietal peritonectomy with involved parietal peritonectomy in CRS and HIPEC for advanced ovarian cancer. It focuses on operative extent within combined cytoreductive surgery and HIPEC treatment pathways.